Novel cancer treatment from Kite Pharma notches positive results, but big questions remain

(By Damian Garde for STAT)

A promising new approach to cancer is moving closer to reaching patients, as the biotech company Kite Pharma prepares to make its case for Food and Drug Administration approval. Continue reading article here……

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.